Clinical Trial Update: High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose radiation therapy with pembrolizumab and chemotherapy in PD-L1–positive metastatic triple-negative breast cancer is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Emory University | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 2 | Status: RECRUITING